CC
ABBV icon

Corton Capital’s AbbVie ABBV Stock Holding History

Corton Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,157
Closed -$322K – 562
2023
Q3 		$322K Sell
2,157
-181
-8% -$26.6K 0.16% 182
2023
Q2 		$315K Sell
2,338
-466
-17% -$68.3K 0.15% 199
2023
Q1 		$447K Buy
2,804
+636
+29% +$97.2K 0.31% 83
2022
Q4 		$350K Buy
+2,168
New +$332K 0.29% 104

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Corton Capital's ABBV Position: Q4 2023 in Review

Corton Capital sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 2,157 shares — an estimated $322K sold.

Corton Capital first reported a position in ABBV in Q4 2022 and held it in 4 quarters. The position peaked at $447K in Q1 2023. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Corton Capital reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
  • Corton Capital sold 2,157 AbbVie shares in Q4 2023, an estimated $322K.
  • Corton Capital first reported a position in AbbVie in Q4 2022 and held it in 4 quarters.
  • Corton Capital's AbbVie position peaked at $447K in Q1 2023.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Corton Capital's 13F filing for Q4 2023, filed 14 Feb 2024.